- Supernus Pharmaceuticals (NASDAQ:SUPN): Q1 EPS of $0.19 misses by $0.04.
- Revenue of $56.37M (+31.0% Y/Y) misses by $3.02M.
- Press Release
Supernus Pharmaceuticals misses by $0.04, misses on revenue
Recommended For You
About SUPN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SUPN | - | - |
Supernus Pharmaceuticals, Inc. |